Page last updated: 2024-08-21

carvacrol and Cirrhoses, Experimental Liver

carvacrol has been researched along with Cirrhoses, Experimental Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashemnia, M; Karimi, J; Khodadadi, I; Mohseni, R; Tavilani, H1
Al-Assaf, AH; Aristatile, B; Pugalendi, KV1

Other Studies

2 other study(ies) available for carvacrol and Cirrhoses, Experimental Liver

ArticleYear
Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl
    Immunopharmacology and immunotoxicology, 2019, Volume: 41, Issue:1

    Topics: Acyltransferases; Animals; Anti-Inflammatory Agents; Apoptosis Regulatory Proteins; Carbon Tetrachloride; Cymenes; Disease Progression; Liver; Liver Cirrhosis, Experimental; Male; Monoterpenes; Rats, Wistar; Signal Transduction; Transcription Factors; Transforming Growth Factor beta; YAP-Signaling Proteins

2019
Carvacrol suppresses the expression of inflammatory marker genes in D-galactosamine-hepatotoxic rats.
    Asian Pacific journal of tropical medicine, 2013, Volume: 6, Issue:3

    Topics: Animals; Blotting, Western; Cyclooxygenase 2; Cymenes; Galactosamine; Interleukin-6; Liver Cirrhosis, Experimental; Male; Monoterpenes; NF-kappa B; Nitric Oxide Synthase Type II; Protective Agents; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Silymarin; Tumor Necrosis Factor-alpha

2013